ireland wound care management investment opportunities, … · sample ireland wound care management...

SAMPLE

Ireland Wound Care Management Investment Opportunities, Analysis and Forecasts to 2018

GMDME0361IDB / Published January 2013

© Global Markets Direct. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form.


Reference Code: GMDME0361IDB

Publication Date: January 2013

SAMPLETable of Contents




1 Table of Contents

1 Table of Contents ........................................................................................................... 2

1.1 List of Tables .......................................................................................................................................................... 7

1.2 List of Figures ...................................................................................................................................................... 11

2 Introduction .................................................................................................................. 14

2.1 What is This Report About? ............................................................................................................................. 14

3 Wound Care Management In Ireland ......................................................................... 15

3.1 Wound Care Management, Ireland, Overall Revenue ($m), USD Constant, 2004-2018 .................. 15

3.2 Wound Care Management, Ireland, Company Share (2010-2011) ........................................................ 21

4 Advanced Wound Management In Ireland ................................................................ 23

4.1 Advanced Wound Management Overall Revenue, (2004-2018) ............................................................. 23

4.1.1 Semi-Permeable Films, Revenue (2004-2018) ....................................................................................... 27

4.1.2 Foams, Revenue (2004-2018) .................................................................................................................... 31

4.1.3 Hydrofibres, Revenue (2004-2018) ............................................................................................................ 33

4.1.4 Hydrocolloids, Revenue (2004-2018) ........................................................................................................ 37

4.1.5 Hydrogels, Revenue (2004-2018) .............................................................................................................. 41

4.1.6 Alginates, Revenue (2004-2018) ................................................................................................................ 45

4.1.7 Collagens, Revenue (2004-2018) .............................................................................................................. 47

4.2 Advanced Wound Management Overall Volume (2004-2018) ................................................................ 51

4.2.1 Semi-Permeable Films, Volume (2004-2018) .......................................................................................... 55

4.2.2 Foams, Volume (2004-2018) ...................................................................................................................... 57

4.2.3 Hydrofibres, Volume (2004-2018) .............................................................................................................. 59

4.2.4 Hydrocolloids, Volume (2004-2018) .......................................................................................................... 61

4.2.5 Hydrogels, Volume (2004-2018) ................................................................................................................. 63

4.2.6 Alginates, Volume (2004-2018) .................................................................................................................. 65

4.2.7 Collagens, Volume (2004-2018) ................................................................................................................. 67

4.3 Advanced Wound Management Average Price (2004-2018) .................................................................. 69

4.4 Advanced Wound Management Distribution Share (2010-2011) .......................................................... 71





4.5 Advanced Wound Management, Ireland, Company Share (2010-2011) .............................................. 72

5 Automated Suturing Devices In Ireland .................................................................... 74

5.1 Automated Suturing Devices Overall Revenue, (2004-2018) ................................................................. 74

5.2 Automated Suturing Devices Overall Volume (2004-2018) ..................................................................... 76

5.3 Automated Suturing Devices Average Price (2004-2018) ....................................................................... 78

5.4 Automated Suturing Devices Distribution Share (2010-2011) ............................................................... 79

6 Compression Therapy In Ireland ................................................................................ 80

6.1 Compression Therapy Overall Revenue, (2004-2018) .............................................................................. 80

6.1.1 Dynamic Compression Therapy, Revenue (2004-2018) ....................................................................... 84

6.1.2 Static Compression Therapy, Revenue (2004-2018) ............................................................................. 88

6.2 Compression Therapy Overall Volume (2004-2018) ................................................................................. 92

6.2.1 Dynamic Compression Therapy, Volume (2004-2018) .......................................................................... 94

6.2.2 Static Compression Therapy, Volume (2004-2018) ................................................................................ 96

6.3 Compression Therapy Average Price (2004-2018) .................................................................................. 100

6.4 Compression Therapy Distribution Share (2010-2011) .......................................................................... 101

6.5 Compression Therapy, Ireland, Company Share (2010-2011) ............................................................. 102

7 Negative Pressure Wound Therapy (NPWT) In Ireland .......................................... 104

7.1 Negative Pressure Wound Therapy (NPWT) Overall Revenue, (2004-2018) .................................... 104

7.1.1 NPWT Sales Business, Revenue (2004-2018) ..................................................................................... 108

7.2 Negative Pressure Wound Therapy NPWT Sales Business, Volume (2004-2018) ......................... 112

7.2.1 NPWT Sales Business, Volume (2004-2018) ........................................................................................ 112

7.3 Negative Pressure Wound Therapy (NPWT) Average Price (2004-2018) .......................................... 114

7.4 Negative Pressure Wound Therapy (NPWT) Distribution Share (2010-2011) ................................. 115

7.4.1 NPWT Rental Business, Ireland, Company Share (2010-2011) ........................................................ 116

7.4.2 NPWT Sales Business, Ireland, Company Share (2010-2011) .......................................................... 117

7.5 Negative Pressure Wound Therapy (NPWT), Ireland, Company Share (2010-2011) ..................... 118





8 Ostomy Drainage Bags In Ireland ............................................................................ 119

8.1 Ostomy Drainage Bags Overall Revenue, (2004-2018) .......................................................................... 119

8.2 Ostomy Drainage Bags Overall Volume (2004-2018) .............................................................................. 123

8.3 Ostomy Drainage Bags Average Price (2004-2018) ................................................................................ 125

8.4 Ostomy Drainage Bags Distribution Share (2010-2011) ........................................................................ 126

8.5 Ostomy Drainage Bags, Ireland, Company Share (2010-2011) ........................................................... 127

9 Pressure Relief Devices In Ireland ........................................................................... 128

9.1 Pressure Relief Devices Overall Revenue, (2004-2018) ......................................................................... 128

9.2 Pressure Relief Devices Overall Volume (2004-2018) ............................................................................ 132

9.3 Pressure Relief Devices Average Price (2004-2018) ............................................................................... 134

9.4 Pressure Relief Devices Distribution Share (2010-2011) ....................................................................... 135

9.4.1 Speciality Beds Rental Business, Ireland, Company Share (2010-2011) ........................................ 136

9.5 Pressure Relief Devices, Ireland, Company Share (2010-2011) .......................................................... 137

10 Traditional Wound Management In Ireland .......................................................... 138

10.1 Traditional Wound Management Overall Revenue, (2004-2018) ......................................................... 138

10.2 Traditional Wound Management Overall Volume (2004-2018) ............................................................. 142

10.3 Traditional Wound Management Average Price (2004-2018) ............................................................... 144

10.4 Traditional Wound Management Distribution Share (2010-2011) ....................................................... 145

10.5 Traditional Wound Management, Ireland, Company Share (2010-2011) ........................................... 146

11 Wound Closure Devices In Ireland ....................................................................... 148

11.1 Wound Closure Devices Overall Revenue, (2004-2018) ........................................................................ 148

11.1.1 Hemostats, Revenue (2004-2018) ........................................................................................................... 152

11.1.2 Tissue Sealants, Revenue (2004-2018) ................................................................................................. 156

11.2 Wound Closure Devices Overall Volume (2004-2018) ............................................................................ 160





11.2.1 Hemostats, Volume (2004-2018) ............................................................................................................. 164

11.2.2 Tissue Sealants, Volume (2004-2018) .................................................................................................... 168

11.3 Wound Closure Devices Average Price (2004-2018) .............................................................................. 170

11.4 Wound Closure Devices Distribution Share (2010-2011) ...................................................................... 172

11.5 Wound Closure Devices, Ireland, Company Share (2010-2011) .......................................................... 173

12 Overview of Key Companies in Ireland Wound Care Management Market ...... 175

12.1 Coloplast A/S ...................................................................................................................................................... 175

12.1.1 Company Overview ..................................................................................................................................... 175

12.2 ConvaTec Inc. ..................................................................................................................................................... 175


12.3 ArjoHuntleigh ..................................................................................................................................................... 176


12.4 Kinetic Concepts, Inc. ...................................................................................................................................... 176


12.5 Smith & Nephew Plc ......................................................................................................................................... 176


12.6 Hollister Incorporated ...................................................................................................................................... 177


12.7 Paul Hartmann AG ............................................................................................................................................ 177


12.8 Molnlycke Health Care AB .............................................................................................................................. 178


12.9 Johnson & Johnson ......................................................................................................................................... 178


12.10 Covidien plc .................................................................................................................................................... 178

12.10.1 Company Overview ................................................................................................................................. 178

12.11 Systagenix Wound Management Limited .............................................................................................. 179






12.12 Hill-Rom Holdings, Inc. ................................................................................................................................ 179


12.13 Synergy Health plc ........................................................................................................................................ 180


12.14 Takeda Pharmaceuticals International GmbH ...................................................................................... 180


12.15 3M Health Care Ltd. ...................................................................................................................................... 181


12.16 B. Braun Melsungen AG .............................................................................................................................. 181


12.17 BSN medical GmbH ...................................................................................................................................... 182


12.18 Advanced Medical Solutions Group plc ................................................................................................. 182


12.19 Baxter International Inc. .............................................................................................................................. 182


12.20 Ethicon, Inc. .................................................................................................................................................... 183


12.21 SIGVARIS, Inc................................................................................................................................................. 183


12.22 Lohmann & Rauscher GmbH & Co. KG .................................................................................................. 183


12.23 Invacare Corporation ................................................................................................................................... 184


12.24 Talley Group Limited .................................................................................................................................... 184


12.25 medi GmbH & Co. KG .................................................................................................................................. 184


13 Appendix .................................................................................................................. 185





13.1 Global Markets Direct Research Methodology ......................................................................................... 185

13.2 Definitions of Markets Covered in the Report .......................................................................................... 186

13.2.1 Wound Care Management ........................................................................................................................ 186

13.3 Secondary Research ........................................................................................................................................ 194

13.4 Primary Research .............................................................................................................................................. 194

13.5 Models .................................................................................................................................................................. 195

13.6 Forecasts ............................................................................................................................................................. 195

13.7 Expert Panel Validation ................................................................................................................................... 195

13.8 Currency Conversion ....................................................................................................................................... 196

13.9 Disclaimer ............................................................................................................................................................ 196

1.1 List of Tables

Table 1: Wound Care Management, Ireland, Overall Revenue ($m), USD Constant, 2004-2018 ..................................... 16

Table 2: Wound Care Management, Ireland, Overall Revenue ($m), USD Constant, Historic, 2004-2011 ..................... 18

Table 3: Wound Care Management, Ireland, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 ................... 20

Table 4: Wound Care Management, Ireland, Company Share by Revenue ($m), USD Constant, 2010-2011 ............... 22

Table 5: Advanced Wound Management, Ireland, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 ... 24

Table 6: Advanced Wound Management, Ireland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 . 26

Table 7: Semi-Permeable Films, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 .......... 28

Table 8: Semi-Permeable Films, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 ........ 30

Table 9: Foams, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 ....................................... 31

Table 10: Foams, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 .................................. 32

Table 11: Hydrofibres, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 ............................ 34

Table 12: Hydrofibres, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 .......................... 36

Table 13: Hydrocolloids, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 ........................ 38

Table 14: Hydrocolloids, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 ...................... 40

Table 15: Hydrogels, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 ............................... 42

Table 16: Hydrogels, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 ............................ 44

Table 17: Alginates, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 ................................ 45

Table 18: Alginates, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 .............................. 46

Table 19: Collagens, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 ............................... 48

Table 20: Collagens, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 ............................. 50





Table 21: Advanced Wound Management, Ireland, Volume (Units) by Segment, Historic, 2004-2011 ............................ 52

Table 22: Advanced Wound Management, Ireland, Volume (Units) by Segment, Forecast, 2011-2018 ......................... 54

Table 23: Semi-Permeable Films, Ireland, Volume (Units) by Sub-Segment, Historic, 2004-2011 ................................... 55

Table 24: Semi-Permeable Films, Ireland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 ................................. 56

Table 25: Foams, Ireland, Volume (Units) by Sub-Segment, Historic, 2004-2011 ............................................................... 57

Table 26: Foams, Ireland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 ............................................................. 58

Table 27: Hydrofibres, Ireland, Volume (Units) by Sub-Segment, Historic, 2004-2011 ....................................................... 59

Table 28: Hydrofibres, Ireland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 ..................................................... 60

Table 29: Hydrocolloids, Ireland, Volume (Units) by Sub-Segment, Historic, 2004-2011 .................................................... 61

Table 30: Hydrocolloids, Ireland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 ................................................. 62

Table 31: Hydrogels, Ireland, Volume (Units) by Sub-Segment, Historic, 2004-2011 .......................................................... 63

Table 32: Hydrogels, Ireland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 ....................................................... 64

Table 33: Alginates, Ireland, Volume (Units) by Sub-Segment, Historic, 2004-2011 ........................................................... 65

Table 34: Alginates, Ireland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 ......................................................... 66

Table 35: Collagens, Ireland, Volume (Units) by Sub-Segment, Historic, 2004-2011 .......................................................... 67

Table 36: Collagens, Ireland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 ........................................................ 68

Table 37: Advanced Wound Management, Ireland, Average Price ($), Historic, 2004-2011 .............................................. 69

Table 38: Advanced Wound Management, Ireland, Average Price ($), Forecast, 2011-2018 ........................................... 70

Table 39: Advanced Wound Management, Ireland, Distribution Share by Revenue ($m), USD Constant, 2010-2011 71

Table 40: Advanced Wound Management, Ireland, Company Share by Revenue ($m), USD Constant, 2010-2011 ... 73

Table 41: Automated Suturing Devices, Ireland, Revenue ($m) USD Constant, Historic, 2004-2011 .............................. 74

Table 42: Automated Suturing Devices, Ireland, Revenue ($m) USD Constant, Forecast, 2011-2018 ............................ 75

Table 43: Automated Suturing Devices, Ireland, Volume (Units), Historic, 2004-2011 ........................................................ 76

Table 44: Automated Suturing Devices, Ireland, Volume (Units), Forecast, 2011-2018 ...................................................... 77

Table 45: Automated Suturing Devices, Ireland, Average Price ($), Historic, 2004-2011 ................................................... 78

Table 46: Automated Suturing Devices, Ireland, Average Price ($), Forecast, 2011-2018 ................................................. 78

Table 47: Automated Suturing Devices, Ireland, Distribution Share by Revenue ($m), USD Constant, 2010-2011 ...... 79

Table 48: Compression Therapy, Ireland, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011.................. 81

Table 49: Compression Therapy, Ireland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 ............... 83

Table 50: Dynamic Compression Therapy, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 .................................................................................................................................................................................................. 85

Table 51: Dynamic Compression Therapy, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 .................................................................................................................................................................................................. 87

Table 52: Static Compression Therapy, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 ........................................................................................................................................................................................................... 89

Table 53: Static Compression Therapy, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 ........................................................................................................................................................................................................... 91

Table 54: Compression Therapy, Ireland, Volume (Units) by Segment, Historic, 2004-2011 ............................................. 92

Table 55: Compression Therapy, Ireland, Volume (Units) by Segment, Forecast, 2011-2018 .......................................... 93

Table 56: Dynamic Compression Therapy, Ireland, Volume (Units) by Sub-Segment, Historic, 2004-2011 ................... 94





Table 57: Dynamic Compression Therapy, Ireland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 ................. 95

Table 58: Static Compression Therapy, Ireland, Volume (Units) by Sub-Segment, Historic, 2004-2011 ......................... 97

Table 59: Static Compression Therapy, Ireland, Volume (Units) by Sub-Segment, Forecast, 2011-2018....................... 99

Table 60: Compression Therapy, Ireland, Average Price ($), Historic, 2004-2011 ............................................................. 100

Table 61: Compression Therapy, Ireland, Average Price ($), Forecast, 2011-2018 .......................................................... 100

Table 62: Compression Therapy, Ireland, Distribution Share by Revenue ($m), USD Constant, 2010-2011 ............... 101

Table 63: Compression Therapy, Ireland, Company Share by Revenue ($m), USD Constant, 2010-2011 .................. 103

Table 64: Negative Pressure Wound Therapy (NPWT), Ireland, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011...................................................................................................................................................................................... 105

Table 65: Negative Pressure Wound Therapy (NPWT), Ireland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018...................................................................................................................................................................................... 107

Table 66: NPWT Sales Business, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 ...... 109

Table 67: NPWT Sales Business, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 .... 111

Table 68: NPWT Sales Business, Ireland, Volume (Units) by Sub-Segment, Historic, 2004-2011 ................................. 112

Table 69: NPWT Sales Business, Ireland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 ............................... 113

Table 70: Negative Pressure Wound Therapy (NPWT), Ireland, Average Price ($), Historic, 2004-2011 ..................... 114

Table 71: Negative Pressure Wound Therapy (NPWT), Ireland, Average Price ($), Forecast, 2011-2018 ................... 114

Table 72: Negative Pressure Wound Therapy (NPWT), Ireland, Distribution Share by Revenue ($m), USD Constant, 2010-2011...................................................................................................................................................................................... 115

Table 73: NPWT Rental Business, Ireland, Company Share by Revenue ($m), USD Constant, 2010-2011 ................ 116

Table 74: NPWT Sales Business, Ireland, Company Share by Revenue ($m), USD Constant, 2010-2011 ................. 117

Table 75: Negative Pressure Wound Therapy (NPWT), Ireland, Company Share by Revenue ($m), USD Constant, 2010-2011...................................................................................................................................................................................... 118

Table 76: Ostomy Drainage Bags, Ireland, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 ............. 120

Table 77: Ostomy Drainage Bags, Ireland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 ........... 122

Table 78: Ostomy Drainage Bags, Ireland, Volume (Units) by Segment, Historic, 2004-2011......................................... 123

Table 79: Ostomy Drainage Bags, Ireland, Volume (Units) by Segment, Forecast, 2011-2018 ...................................... 124

Table 80: Ostomy Drainage Bags, Ireland, Average Price ($), Historic, 2004-2011 ........................................................... 125

Table 81: Ostomy Drainage Bags, Ireland, Average Price ($), Forecast, 2011-2018 ........................................................ 125

Table 82: Ostomy Drainage Bags, Ireland, Distribution Share by Revenue ($m), USD Constant, 2010-2011 ............. 126

Table 83: Ostomy Drainage Bags, Ireland, Company Share by Revenue ($m), USD Constant, 2010-2011 ................ 127

Table 84: Pressure Relief Devices, Ireland, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 ............ 129

Table 85: Pressure Relief Devices, Ireland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 .......... 131

Table 86: Pressure Relief Devices, Ireland, Volume (Units) by Segment, Historic, 2004-2011 ....................................... 132

Table 87: Pressure Relief Devices, Ireland, Volume (Units) by Segment, Forecast, 2011-2018 ..................................... 133

Table 88: Pressure Relief Devices, Ireland, Average Price ($), Historic, 2004-2011 ......................................................... 134

Table 89: Pressure Relief Devices, Ireland, Average Price ($), Forecast, 2011-2018 ....................................................... 134

Table 90: Pressure Relief Devices, Ireland, Distribution Share by Revenue ($m), USD Constant, 2010-2011 ............ 135

Table 91: Speciality Beds Rental Business, Ireland, Company Share by Revenue ($m), USD Constant, 2010-2011 136

Table 92: Pressure Relief Devices, Ireland, Company Share by Revenue ($m), USD Constant, 2010-2011 ............... 137





Table 93: Traditional Wound Management, Ireland, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 ......................................................................................................................................................................................................... 139

Table 94: Traditional Wound Management, Ireland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 ......................................................................................................................................................................................................... 141

Table 95: Traditional Wound Management, Ireland, Volume (Units) by Segment, Historic, 2004-2011 ......................... 142

Table 96: Traditional Wound Management, Ireland, Volume (Units) by Segment, Forecast, 2011-2018....................... 143

Table 97: Traditional Wound Management, Ireland, Average Price ($), Historic, 2004-2011 ........................................... 144

Table 98: Traditional Wound Management, Ireland, Average Price ($), Forecast, 2011-2018......................................... 144

Table 99: Traditional Wound Management, Ireland, Distribution Share by Revenue ($m), USD Constant, 2010-2011 ......................................................................................................................................................................................................... 145

Table 100: Traditional Wound Management, Ireland, Company Share by Revenue ($m), USD Constant, 2010-2011 ......................................................................................................................................................................................................... 147

Table 101: Wound Closure Devices, Ireland, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 .......... 149

Table 102: Wound Closure Devices, Ireland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 ....... 151

Table 103: Hemostats, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 ......................... 153

Table 104: Hemostats, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 ....................... 155

Table 105: Tissue Sealants, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 ................ 157

Table 106: Tissue Sealants, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 ............. 159

Table 107: Wound Closure Devices, Ireland, Volume (Units) by Segment, Historic, 2004-2011 ..................................... 161

Table 108: Wound Closure Devices, Ireland, Volume (Units) by Segment, Forecast, 2011-2018 .................................. 163

Table 109: Hemostats, Ireland, Volume (Units) by Sub-Segment, Historic, 2004-2011 .................................................... 165

Table 110: Hemostats, Ireland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 .................................................. 167

Table 111: Tissue Sealants, Ireland, Volume (Units) by Sub-Segment, Historic, 2004-2011 ........................................... 168

Table 112: Tissue Sealants, Ireland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 ........................................ 169

Table 113: Wound Closure Devices, Ireland, Average Price ($), Historic, 2004-2011 ....................................................... 170

Table 114: Wound Closure Devices, Ireland, Average Price ($), Forecast, 2011-2018..................................................... 171

Table 115: Wound Closure Devices, Ireland, Distribution Share by Revenue ($m), USD Constant, 2010-2011 ......... 172

Table 116: Wound Closure Devices, Ireland, Company Share by Revenue ($m), USD Constant, 2010-2011 ............ 174





1.2 List of Figures

Figure 1: Wound Care Management, Ireland, Overall Revenue ($m), USD Constant, 2004-2018 ................................... 15

Figure 2: Wound Care Management, Ireland, Overall Revenue ($m), USD Constant, Historic, 2004-2011 .................... 17

Figure 3: Wound Care Management, Ireland, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 ................. 19

Figure 4: Wound Care Management, Ireland, Company Share (%) 2011 .............................................................................. 21

Figure 5: Advanced Wound Management, Ireland, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 . 23

Figure 6: Advanced Wound Management, Ireland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 25

Figure 7: Semi-Permeable Films, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 ......... 27

Figure 8: Semi-Permeable Films, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 ...... 29

Figure 9: Foams, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 ..................................... 31

Figure 10: Foams, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 ................................. 32

Figure 11: Hydrofibres, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 ........................... 33

Figure 12: Hydrofibres, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018......................... 35

Figure 13: Hydrocolloids, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 ....................... 37

Figure 14: Hydrocolloids, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 ..................... 39

Figure 15: Hydrogels, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 ............................. 41

Figure 16: Hydrogels, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 ........................... 43

Figure 17: Alginates, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 ............................... 45

Figure 18: Alginates, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 ............................. 46

Figure 19: Collagens, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 ............................. 47

Figure 20: Collagens, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 ........................... 49

Figure 21: Advanced Wound Management, Ireland, Volume (Units) by Segment, Historic, 2004-2011 .......................... 51

Figure 22: Advanced Wound Management, Ireland, Volume (Units) by Segment, Forecast, 2011-2018 ........................ 53

Figure 23: Semi-Permeable Films, Ireland, Volume (Units) by Sub-Segment, Historic, 2004-2011 .................................. 55

Figure 24: Semi-Permeable Films, Ireland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 ............................... 56

Figure 25: Foams, Ireland, Volume (Units) by Sub-Segment, Historic, 2004-2011 .............................................................. 57

Figure 26: Foams, Ireland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 ............................................................ 58

Figure 27: Hydrofibres, Ireland, Volume (Units) by Sub-Segment, Historic, 2004-2011 ...................................................... 59

Figure 28: Hydrofibres, Ireland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 .................................................... 60

Figure 29: Hydrocolloids, Ireland, Volume (Units) by Sub-Segment, Historic, 2004-2011 .................................................. 61

Figure 30: Hydrocolloids, Ireland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 ................................................ 62

Figure 31: Hydrogels, Ireland, Volume (Units) by Sub-Segment, Historic, 2004-2011 ........................................................ 63

Figure 32: Hydrogels, Ireland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 ...................................................... 64

Figure 33: Alginates, Ireland, Volume (Units) by Sub-Segment, Historic, 2004-2011 .......................................................... 65

Figure 34: Alginates, Ireland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 ........................................................ 66

Figure 35: Collagens, Ireland, Volume (Units) by Sub-Segment, Historic, 2004-2011......................................................... 67

Figure 36: Collagens, Ireland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 ...................................................... 68

Figure 37: Advanced Wound Management, Ireland, Company Share (%), 2011 ................................................................. 72





Figure 38: Automated Suturing Devices, Ireland, Revenue ($m) USD Constant, Historic, 2004-2011 ............................. 74

Figure 39: Automated Suturing Devices, Ireland, Revenue ($m) USD Constant, Forecast, 2011-2018 .......................... 75

Figure 40: Automated Suturing Devices, Ireland, Volume (Units), Historic, 2004-2011 ...................................................... 76

Figure 41: Automated Suturing Devices, Ireland, Volume (Units), Forecast, 2011-2018 .................................................... 77

Figure 42: Compression Therapy, Ireland, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 ................ 80

Figure 43: Compression Therapy, Ireland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 .............. 82

Figure 44: Dynamic Compression Therapy, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 .................................................................................................................................................................................................. 84

Figure 45: Dynamic Compression Therapy, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 .................................................................................................................................................................................................. 86

Figure 46: Static Compression Therapy, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 ........................................................................................................................................................................................................... 88

Figure 47: Static Compression Therapy, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 .................................................................................................................................................................................................. 90

Figure 48: Compression Therapy, Ireland, Volume (Units) by Segment, Historic, 2004-2011 ........................................... 92

Figure 49: Compression Therapy, Ireland, Volume (Units) by Segment, Forecast, 2011-2018 ......................................... 93

Figure 50: Dynamic Compression Therapy, Ireland, Volume (Units) by Sub-Segment, Historic, 2004-2011 .................. 94

Figure 51: Dynamic Compression Therapy, Ireland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 ............... 95

Figure 52: Static Compression Therapy, Ireland, Volume (Units) by Sub-Segment, Historic, 2004-2011 ....................... 96

Figure 53: Static Compression Therapy, Ireland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 ..................... 98

Figure 54: Compression Therapy, Ireland, Company Share (%), 2011 ................................................................................ 102

Figure 55: Negative Pressure Wound Therapy (NPWT), Ireland, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011...................................................................................................................................................................................... 104

Figure 56: Negative Pressure Wound Therapy (NPWT), Ireland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018...................................................................................................................................................................................... 106

Figure 57: NPWT Sales Business, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 ..... 108

Figure 58: NPWT Sales Business, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 .. 110

Figure 59: NPWT Sales Business, Ireland, Volume (Units) by Sub-Segment, Historic, 2004-2011 ................................ 112

Figure 60: NPWT Sales Business, Ireland, Volume (Units) by Sub-Segment, Forecast, 2011-2018.............................. 113

Figure 61: NPWT Rental Business, Ireland, Company Share (%), 2011 .............................................................................. 116

Figure 62: NPWT Sales Business, Ireland, Company Share (%), 2011 ............................................................................... 117

Figure 63: Negative Pressure Wound Therapy (NPWT), Ireland, Company Share (%), 2011 ......................................... 118

Figure 64: Ostomy Drainage Bags, Ireland, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 ............ 119

Figure 65: Ostomy Drainage Bags, Ireland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 .......... 121

Figure 66: Ostomy Drainage Bags, Ireland, Volume (Units) by Segment, Historic, 2004-2011 ....................................... 123

Figure 67: Ostomy Drainage Bags, Ireland, Volume (Units) by Segment, Forecast, 2011-2018 ..................................... 124

Figure 68: Ostomy Drainage Bags, Ireland, Company Share (%), 2011 .............................................................................. 127

Figure 69: Pressure Relief Devices, Ireland, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 ........... 128

Figure 70: Pressure Relief Devices, Ireland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018......... 130

Figure 71: Pressure Relief Devices, Ireland, Volume (Units) by Segment, Historic, 2004-2011 ...................................... 132

Figure 72: Pressure Relief Devices, Ireland, Volume (Units) by Segment, Forecast, 2011-2018 .................................... 133





Figure 73: Speciality Beds Rental Business, Ireland, Company Share (%), 2011 .............................................................. 136

Figure 74: Pressure Relief Devices, Ireland, Company Share (%), 2011 ............................................................................. 137

Figure 75: Traditional Wound Management, Ireland, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 ......................................................................................................................................................................................................... 138

Figure 76: Traditional Wound Management, Ireland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 ......................................................................................................................................................................................................... 140

Figure 77: Traditional Wound Management, Ireland, Volume (Units) by Segment, Historic, 2004-2011 ....................... 142

Figure 78: Traditional Wound Management, Ireland, Volume (Units) by Segment, Forecast, 2011-2018 ..................... 143

Figure 79: Traditional Wound Management, Ireland, Company Share (%), 2011 .............................................................. 146

Figure 80: Wound Closure Devices, Ireland, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 ........... 148

Figure 81: Wound Closure Devices, Ireland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 ........ 150

Figure 82: Hemostats, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 .......................... 152

Figure 83: Hemostats, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 ........................ 154

Figure 84: Tissue Sealants, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 ................. 156

Figure 85: Tissue Sealants, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 .............. 158

Figure 86: Wound Closure Devices, Ireland, Volume (Units) by Segment, Historic, 2004-2011 ...................................... 160

Figure 87: Wound Closure Devices, Ireland, Volume (Units) by Segment, Forecast, 2011-2018 ................................... 162

Figure 88: Hemostats, Ireland, Volume (Units) by Sub-Segment, Historic, 2004-2011 ..................................................... 164

Figure 89: Hemostats, Ireland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 ................................................... 166

Figure 90: Tissue Sealants, Ireland, Volume (Units) by Sub-Segment, Historic, 2004-2011 ............................................ 168

Figure 91: Tissue Sealants, Ireland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 ......................................... 169

Figure 92: Wound Closure Devices, Ireland, Company Share (%), 2011 ............................................................................. 173

Figure 93: Global Markets Direct Methodology .......................................................................................................................... 185

SAMPLEIntroduction




2 Introduction

Global Markets Direct’s medical equipment market reports are ideal guide for anyone wishing to

understand their market better in terms of revenues, unit sales, distribution share and company

share.

2.1 What is This Report About?

Ireland wound care management report provides an overview of the following information:

1. Comprehensive data related to the market revenue, unit sale, average price, distribution

share and company share.

2. Global corporate-level profiles of key companies operating in the wound care management

market in Ireland, which includes a brief overview of the company. The selection of the

companies is based on their operational presence in Ireland; it includes key multinationals

as well as key local players.

SAMPLEWound Care Management in Ireland




3 Wound Care Management In Ireland

3.1 Wound Care Management, Ireland, Overall Revenue ($m), USD Constant, 2004-2018

Figure 1: Wound Care Management, Ireland, Overall Revenue ($m), USD Constant, 2004-2018

Source: Global Markets Direct





Table 1: Wound Care Management, Ireland, Overall Revenue ($m), USD Constant, 2004-2018

Category 2004 2011 2018 CAGR 04-11 CAGR 11-18 CAGR 04-18

Ostomy Drainage Bags

Advanced Wound Management

Wound Closure Devices

Traditional Wound Management

Pressure Relief Devices

Compression Therapy

Negative Pressure Wound Therapy (NPWT)

Automated Suturing Devices

Total






Figure 2: Wound Care Management, Ireland, Overall Revenue ($m), USD Constant, Historic, 2004-

2011






Table 2: Wound Care Management, Ireland, Overall Revenue ($m), USD Constant, Historic, 2004-

2011

Category 2004 2005 2006 2007 2008 2009 2010 2011 CAGR


% Growth


% Growth


% Growth


% Growth


% Growth

Compression Therapy

% Growth


% Growth


% Growth

Total

% Growth






Figure 3: Wound Care Management, Ireland, Overall Revenue ($m), USD Constant, Forecast, 2011-

2018






Table 3: Wound Care Management, Ireland, Overall Revenue ($m), USD Constant, Forecast, 2011-

2018

Category 2011 2012 2013 2014 2015 2016 2017 2018 CAGR


% Growth


% Growth


% Growth


% Growth


% Growth


% Growth

Compression Therapy

% Growth


% Growth

Total

% Growth






3.2 Wound Care Management, Ireland, Company Share (2010-2011)

Figure 4: Wound Care Management, Ireland, Company Share (%) 2011

Note: Company Share estimates are based on company reports, secondary research and primary research






Table 4: Wound Care Management, Ireland, Company Share by Revenue ($m), USD Constant,

2010-2011

Company Name 2010 2011

Coloplast A/S

ConvaTec Inc.

ArjoHuntleigh

Kinetic Concepts, Inc.

Smith & Nephew Plc

Hollister Incorporated

Paul Hartmann AG

Molnlycke Health Care AB

Johnson & Johnson

Covidien plc

Systagenix Wound Management Limited

Hill-Rom Holdings, Inc.

Synergy Health plc

Takeda Pharmaceuticals International GmbH

3M Health Care Ltd.

B. Braun Melsungen AG

BSN medical GmbH

Advanced Medical Solutions Group plc

Baxter International Inc.

Ethicon, Inc.

Others

Total


SAMPLEAppendix



© Global Markets Direct. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form. Page 185

TaxonomyUpdate

Forecasts

Expert Panelvalidation

SecondaryResearch

PrimaryResearch

Modelingand

Benchmarking

Data UpdateTaxonomy

Update

Forecasts

Expert Panelvalidation

SecondaryResearch

PrimaryResearch

Modelingand

Benchmarking

Data Update

13 Appendix

13.1 Global Markets Direct Research Methodology

Global Markets Direct’s dedicated research and analysis teams are experienced professionals with

expertise in marketing, market research, consulting background in the medical devices industry

and advanced statistical expertise.

Global Markets Direct adheres to the codes of practice of the Market Research Society

(www.mrs.org.uk) and the Strategic and Competitive Intelligence Professionals (www.scip.org).

All Global Markets Direct databases are continuously updated and revised. The following research

methodology is followed for all databases and reports.

Figure 93: Global Markets Direct Methodology


SAMPLEAppendix




13.2 Definitions of Markets Covered in the Report

13.2.1 Wound Care Management

The wound care management market comprises of dressings, equipment and other aids to

prevent, treat wounds and also quicken or promote wound healing. The wound care management

market covers traditional wound management, advanced wound management, Negative Pressure

Wound Therapy (NPWT), wound closure devices, ostomy drainage bags, pressure relief devices,

compression therapy, tissue engineering and automated suturing devices.

13.2.1.1 Advanced Wound Management

Advanced wound management involves use of dressing products combined with drug formulations

to provide enhanced healing properties. These dressings provide a moist and active dressings

environment for optimum healing. Active dressings are based on biomaterials such as collagens.

Similarly, moist dressings include materials such as hydrogels. This category includes semi-

permeable films, foams, hydrofibres, hydrocolloids, hydrogels, alginates, collagens and wound

contact layer dressings.

Alginates

This dressing includes alginates derived from the naturally occurring calcium and sodium salt of

alginic acid produced by a family of brown seaweed (Phaeophyceae). Alginate dressing forms a

moist gel in the presence of wound exudates. Alginate dressings fall into two kinds: those

containing 100% calcium alginate and those that contain a combination of calcium with sodium

alginate, usually in a ratio of 80:20. Both types are covered. One unit refers to pack of 10 Alginate

dressings.

Antimicrobial Alginate Dressings

These alginates dressing are impregnated with an agent that inhibits microbial growth. One unit

refers to pack of 10 alginate dressings.

Non Antimicrobial Alginate Dressings

These alginate based dressings do not have antimicrobial activity due to absence of anti microbial

agents. One unit refers to pack of 10 alginate dressings.

Collagens

This segment includes dressings that are typically made up of a combination of animal collagen

and any other formulation (such as cellulose or alginates) for structural integrity and sodium or

calcium ions. These are available in many forms (sheets, gels, pads, particles and pastes) but only

sheets and pads are tracked within this segment. One unit refers to a pack of 10 collagen

dressings.

SAMPLEAppendix




Antimicrobial Collagen Dressings

The collagen dressings are impregnated with an agent that inhibits microbial growth. One unit

refers to pack of 10 collagen dressings.

Non Antimicrobial Collagen Dressings

These are collagen based dressings lacking any type of antimicrobial agent. One unit refers to a

pack of 10 collagen dressings.

Foams

Foam dressings are made up of either a hydrophilic polyurethane or silicon foam matrix for

moisture control in wounds. Polyurethane foams consist of a hydrophilic wound contact surface

and a hydrophobic backing, which makes them highly absorbent. One unit refers to pack of 10

films.

Antimicrobial Foam Dressings

Foams impregnated with an agent which inhibits microbial growth. One unit refers to a pack of 10

foam dressings.

Non Antimicrobial Foam Dressings

These are foam based dressings that do not contain any antimicrobial agent. One unit refers to a

pack of 10 foam dressings.

Hydrocolloids

A flat, waterproof, occlusive dressing that consists of a mixture of pectins, gelatins, sodium

carboxymethylcellulose and elastomers. This dressing forms a gel on the wound surface,

promoting moist wound healing. Only self-adhesive pads are tracked within this segment. One unit

refers to a pack of 10 hydrocolloid dressings.

Antimicrobial Hydrocolloid Dressings

The hydrocolloid dressing impregnated with an agent which inhibits microbial growth. One unit

refers to a pack of 10 hydrocolloid dressings.

Non Antimicrobial Hydrocolloid Dressings

These hydrocolloid dressings are devoid of anti microbial agents and have no impact on microbial

growth. One unit refers to a pack of 10 hydrocolloid dressings.

Hydrofibres

Hydrofibres are hydrophilic, non-woven sheets or ribbon dressings composed of sodium

carboxymethylcellulose (CMC). On contact with exudates, fibers are converted from a dry dressing

to a soft coherent gel sheet, making them suitable for wounds with large amount of exudates. One

unit refers to a pack of 10 hydrofibre dressings.

SAMPLEAppendix




Antimicrobial Hydrofibre Dressings

These hydrofibre dressing are impregnated with an agent that inhibits microbial growth. One unit

refers to a pack of 10 hydrofibre dressings.

Non Antimicrobial Hydrofibre Dressings

These are hydrofibre dressings lacking antimicrobial activity due to absence of anti microbial

agents. One unit refers to a pack of 10 hydrofibre dressings.

Hydrogels

Hydrogels consist of 96% water with a matrix of insoluble polymers embedded in it. The former

helps maintain a moist wound environment while the latter facilitates absorption of wound

exudates. One unit refers to a pack of 10 dressings.

Antimicrobial Hydrogel Dressings

This type of hydrogel dressing is impregnated with an agent that inhibits microbial growth. One unit

refers to a pack of 10 hydrogel dressings.

Non Antimicrobial Hydrogel Dressings

These are hydrogel dressings lacking antimicrobial activity due to absence of anti microbial

agents. One unit refers to a pack of 10 hydrogel dressings.

Semi-Permeable Films

Semi-Permeable films are sterile plastic sheets of polyurethane coated with hypoallergenic acrylic

adhesive, used to protect shallow, minor wounds from dirt, fluid and bacteria. One unit refers to a

pack of 10 semi-permeable films.

Antimicrobial Film Dressings

These semi-permeable films are impregnated with an agent that inhibits microbial growth. One unit

refers to a pack of 10 semi-permeable films.

Non Antimicrobial Film Dressings

These are semi-permeable film dressings lacking antimicrobial activity due to absence of anti

microbial agents. One unit refers to a pack of 10 semi-permeable films.

Wound Contact Layers

A wound contact layer is ideal for use on wounds with fragile surrounding skin because it is non-

adherent and incredibly gentle on the skin. This dressing ensures a moist wound environment

while protecting the sensitive granulated wound bed. One unit refers to a pack of 10 dressings.

13.2.1.2 Automated Suturing Devices

An automated suturing device automatically stitches the adjoining tissue layer edges by repeatedly

passing a needle and the attached thread without the need of manual intervention. One unit refers

to a single device.

SAMPLEAppendix




13.2.1.3 Compression Therapy

Compression therapy involves static compression devices such as compression bandages, ready-

to-wear legwear, anti embolism stockings, diabetic shoes and dynamic compression devices such

as intermittent pumps and segmental/sequential pumps to treat vascular diseases such as venous

ulcers.

Dynamic Compression Therapy

Dynamic compression is mechanical compression applied by a mechanical pumping device

(pumps and sleeves). The pressure is applied starting from the foot proceeding towards the lower

leg and ending just below the knee.

Intermittent Pumps

Intermittent pumps provide compression therapy by compressing and decompressing the leg. The

pump inflates and deflates the sleeve in one motion and with uniform pressure along the sleeve.

One unit refers to a single pump.

Segmental/Sequential Pumps

Segmental pumps use a multi-chambered garment, that is filled sequentially, to, provide

compression therapy by compressing and decompressing the leg. The pressure applied on the

segments of the sleeves is uniform but the segments are deflated and inflated individually. One

unit refers to a single pump.

Static Compression Therapy

Static compression therapy involves application of graduated pressure starting from the ankle, up

the lower leg and ending below the knee. The distal portion of the bandage applies greater

pressure and the pressure decreases gradually towards the proximal portion of the bandage.

Generally the pressure averages between 30 mmHg and 40 mmHg. The exact pressure varies

according to the type of garments or stockings used. Static compression therapy devices are

segmented into ready-to-wear legwear, anti embolism stockings, diabetic shoes and compression

bandages.

Anti Embolism Stockings

Anti-embolism stockings are designed for bed bound patients to help prevent blood from pooling in

the veins of the leg leading to blood clots. These stockings are apt for short duration of wear during

hospitalization to deliver gradient compression ranging from 12 to 20 mmHg. These stockings are

normally available only in white and have an opening on the underside of the toes which can be

uncomfortable while walking. One unit refers to a pair of anti embolism stockings.

Compression Bandages

Compression bandages involve deliberate application of pressure to treat venous disorders of the

lower limbs like edema and swelling. Based on the level of compression produced, compression

bandages have been classified as light compression bandages, moderate compression bandages,

SAMPLEAppendix




high compression bandages and extra-high performance compression bandages. 1 unit = 1 Roll of

4x10 Yards.

Diabetic Shoes

Diabetic shoes are specifically designed therapeutic shoes which are wider and deeper than a

regular shoe. These reduce the risk of foot injuries or skin breakdown in patients suffering from

diabetes. One unit refers to a pair of diabetic shoes.

Ready-to-Wear Legwear

Ready-to-wear legwear are exceptionally durable and comfortable and provide low to medium

level of compression that ensures continuous blood flow throughout the veins. These are typically

prescribed by a medical practitioner or an extended care facility to patients after discharge from

hospital. These can be worn comfortably for long duration of time. One unit refers to a pair of

ready-to-wear legwear.

13.2.1.4 Negative Pressure Wound Therapy (NPWT)

Negative Pressure Wound Therapy (NPWT) involves the use of sub-atmospheric pressure to

enhance wound healing, or remove exudate from a wound. Revenues from sales and rent of

NPWT equipment and sales of NPWT disposables have been considered in this category.

NPWT Rental Business

Revenue generated from rent of NPWT equipment to consumers, healthcare facilities like acute

care hospitals and extended care hospitals have been covered here.

NPWT Sales Business

Revenue generated from sale of NPWT equipment to consumers, healthcare facilities like acute

care hospitals and extended care hospitals have been covered here.

NPWT Disposables

NPWT disposables are consumables used with NPWT equipment. It includes canister, dressing

and tubing. One unit is equal to one disposable kit.

NPWT Equipment

It is a non-invasive system that creates and delivers a negative pressure at the wound site

enhancing the vascularity and oxygen content of the wound. A tube decompresses a foam

dressing, continuously or intermittently to remove the exudates from a wound. One unit refers to

single equipment.

SAMPLEAppendix




13.2.1.5 Ostomy Drainage Bags

Ostomy drainage bags are used for collection of waste fluids from the stomach through an artificial

opening created through a surgical procedure called ostomy. Ostomy devices such as ostomy

pouches and related accessories are covered under this category.

Colostomy

After a colostomy procedure, a part of the colon is attached to the anterior abdominal wall, leaving

a stoma in its place and a colostomy bag/ pouch is attached to the stoma to get rid of fecal matter.

There are various types of pouches: open ended, close ended or one piece (in which the skin

adhesive is attached with it and the pouch with the skin adhesive is considered as a unit). One unit

refers to a pack of 10 bags.

Ileostomy

Ileostomy bags are usually located above the groin towards the right hand side and are used for

disposal of body matter from a stoma in the abdomen. These can be either temporary or

permanent. One unit refers to a pack of 10 bags.

Urostomy

Urostomy bags are used to collect urine after a urostomy procedure. Most urostomy bags/pouches

have an anti-reflux valve to stop back-flow in to the system. These can be either temporary or

permanent. One unit refers to a pack of 10 bags.

13.2.1.6 Pressure Relief Devices

Pressure relief devices include devices that provide a conforming support surface and distribute

body weight over a large area. Revenues from sales and rent of speciality beds and sales of

mattresses replacement made of foam, air, gel or fluid; and mattresses overlay made of foam, gel

or air are included under this category.

Mattress Overlays

An additional support surface designed to be placed directly on an existing mattress. Mattress

overlays filled with foam, gel or air are covered under this segment. One unit refers to a single

mattress overlay.

Mattresses

Mattress replacement is a support surface that totally replaces the standard mattress for pressure

ulcer management. Standard foam mattresses, alternative foam mattresses, gel filled mattresses,

air filled mattresses and fluid filled mattresses are covered under this segment. One unit refers to a

single mattress.

SAMPLEAppendix




Speciality Beds Rental Business

Revenue generated from rent of speciality beds to consumers, healthcare facilities like acute care

hospitals and extended care hospitals has been covered here.

Speciality Beds Sales Business

This includes motor driven turning or tilting beds that aid in manual repositioning of the patient

suffering from different medical conditions. One unit refers to a single bed.

13.2.1.7 Traditional Wound Management

Traditional wound management comprises the traditional devices like gauzes, sponges and

bandages.

Bandages

A bandage is a portion of material which provides body support. It also serves to support a medical

device like a dressing or splint. Compression bandages are not included here. One unit refers to a

pack of 50 Bandages.

Gauzes

Gauzes are translucent cotton dressings used for dressing wounds while ensuring minimal

adhesion. Rolls of gauze have been included. One unit refers to a pack of 50.

Sponges

Sponges are used to absorb body fluids and provide protection from dirt and bacteria. ABD pads,

Non Adherent dressings, gauze fluff rolls and self adhering foam, both sterile and non sterile ones,

are included here. One unit refers to a pack of 50.

13.2.1.8 Wound Closure Devices

Wound closure devices are used to close wounds that occur due to injuries or surgical procedures.

This category includes hemostats, tissue sealants, mechanical stapling devices, ligating clips and

wound closure strips.

Hemostats

Hemostats are used to improve haemostasis and promote wound healing after a surgical

procedure. They contain fibrinogen, thrombin and other plasma proteins which helps promote

clotting, formation and cross-linking of fibrin. Only hemostats in the form of matrix and gauze are

included. One unit refers to a pack of 10.

Collagen Based Hemostats

Collagen based hemostats are composed of resorbable microfibrillar collagen. They attract

platelets thereby promoting the formation of a blood clot when they come into contact with blood.

Only hemostats in the form of matrix and gauze are included. One unit refers to a pack of 10.

Oxidized Regenerated Cellulose Based Hemostats

SAMPLEAppendix




Oxidized regenerated cellulose based hemostats are poly anions having polyanhydroglucuronic

acid as a functional unit which aids platelets to commence the adhesion and aggregation process

leading to coagulation. Only hemostats in the form of matrix and gauze are included. One unit

refers to a pack of 10.

Thrombin Based Hemostats

Thrombin based hemostat transforms fibrinogen into fibrin, activates factor XIII and promotes

stabilization of the clot formed by fibrin and other proteins. Only hemostats in the form of matrix

and gauze are included. One unit refers to a pack of 10.

Ligating Clips

Ligating clips are made up of titanium and conventionally used for clamping tissues as needed

during various procedures. One unit refers to one cartridge containing 6 ligating clips.

Mechanical Stapling Devices

Mechanical stapling devices are hand held wound closure devices used to fix the staples after

surgery. This includes stapling equipment and staples. These devices may either be disposable or

reusable. One unit refers to one stapling device.

Tissue Sealants

Tissue sealant is a type of surgical tissue adhesive that is used to control bleeding during surgery.

This category includes internal sealants and external sealants.

External Sealants

External sealants are the synthetic sealants which bind covalently to tissue surface proteins.

External sealants consist of cyanoacrylate glue and polyethylene glycol hydrogels. One unit of

external sealants refers to 5 ml vial.

Internal Sealants

Internal sealants are the tissue adhesives which assist in the process of coagulation by delivering

fibrinogen to the affected area. Internal sealants consist of fibrin sealants consists of fibrin

sealants and protein sealants. One unit of internal sealants refers to 5 ml vial.

Wound Closure Strips

Wound closure strips are adhesive strip-like bandages that aid in sealing wounds of the skin thus

eliminating the requirement of surface stitches or staples. One unit refers to a pack of 50 strips.

13.2.1.9 Wound Debridement Devices

Wound debridement devices are used for cleansing of wounds and elimination of devitalized tissue

to enhance wound healing. Ultrasonic and hydrotherapy devices have been tracked here. Scalpels

and curettes are not included. One unit refers to a single device.

SAMPLEAppendix




Note: 1). Value, distribution and company shares figures reflect annual gross sales of wound care

management in local currency converted to $ at constant rate. Volume figures reflect the annual

unit sales of wound care management. The annual growth (year on year growth) and compounded

annual growth rate (CAGR) in tables is rounded off to one decimal place.

2). Company share data represents market share (in revenues and as percentage to total market)

of companies in market categories and geographies tracked. The data is rounded off to the

nearest decimal places.

13.3 Secondary Research

The research process begins with exhaustive secondary research on internal and external sources being

carried out to source qualitative and quantitative information relating to each market.

The secondary research sources that are typically referred to include, but are not limited to:

o Company websites, annual reports, financial reports, broker reports, investor presentations and

SEC Filings

o Industry trade journals, scientific journals and other technical literature

o Internal and external proprietary databases

o Relevant patent and regulatory databases

o National government documents, statistical databases and market reports

o Procedure registries and

o News articles, press releases and web-casts specific to the companies operating in the market

13.4 Primary Research

Global Markets Direct conducts thousands of primary interviews a year with industry participants and

commentators in order to validate its data and analysis. A typical research interview fulfills the following

functions:

o It provides first-hand information on the market size, market trends, growth trends, competitive

landscape, future outlook etc.

o Helps in validating and strengthening the secondary research findings.

o Further develops the Analysis Team’s expertise and market understanding.

Primary research involves e-mail interactions and telephonic interviews for each market, category,

segment and sub-segment across geographies.

The participants who typically take part in such a process include, but are not limited to:

o Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers

and national sales managers

o Hospital stores, laboratories, pharmacies, distributors and paramedics;

SAMPLEAppendix




o Outside experts: Investment Bankers, Valuation Experts, Research Analysts specializing in

specific medical equipment markets and.

o Key Opinion Leaders: Physicians and surgeons specializing in different therapeutic areas

corresponding to different kinds of medical equipment.

13.5 Models

Where no hard data is available Global Markets Direct uses modeling and estimates in order to produce

comprehensive data sets. The following rigorous methodology is adopted:

Available hard data is cross referenced with the following data types to produce estimates:

o Demographic data: Population split by segment,

o Macro-economic Indicators: GDP, inflation rate etc,

o Healthcare Indicators: Health expenditure, Physicians Base, healthcare infrastructure and

facilities and

o Selected epidemiological and procedure statistics

Data is then cross checked by the expert panel.

13.6 Forecasts

Global Markets Direct uses proprietary forecast models. The following four factors are utilized in the

forecast models:

Historic growth rates

Macro indicators such as population trends and healthcare spending

Forecast epidemiological data

Qualitative trend information and assumptions

Data is then cross checked by the expert panel.

13.7 Expert Panel Validation

Global Markets Direct uses a panel of experts to cross verify its databases and forecasts.

Global Markets Direct expert panel comprises of marketing managers, product specialists, international

sales managers from medical device companies; academicians from research universities, KOLs from

hospitals, consultants from venture capital funds and distributors/suppliers of medical equipment and

supplies etc.

Historic data and forecasts are relayed to Global Markets Direct’s Expert Panel for feedback and

adjusted in accordance with their feedback.

SAMPLEAppendix




13.8 Currency Conversion

The Currency Conversion rate is based on 2011 average rate 1 USD = 0.719 EUR

13.9 Disclaimer

All Rights Reserved.

No part of this publication may be reproduced, stored in a retrieval system or transmitted in any

form by any means, electronic, mechanical, photocopying, recording or otherwise without the prior

permission of the publisher, Global Markets Direct.

ireland wound care management investment opportunities, … · sample ireland wound care management...

Documents